Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Care Facilities

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment`s hospice services comprise in-home services to terminally ill patients and their families to address patients` physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of June 15, 2020, Encompass Health Corporation operated 136 hospitals, 245 home health locations, and 83 hospice locations in 39 states and Puerto Rico...
Website: encompasshealth.com



Growth: Pretty weak revenue growth rate 10.0%, there is acceleration compared to average historical growth rates 7.2%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +5.9%

Profitability: LTM EBITDA margin is positive, +21.6%. In the last quarter the company beat the estimated EPS, +25.7%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of -$0.07 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.7%. Free cash flow yield 0.6% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 88.4% higher than minimum and 23.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.9x by EV / Sales multiple , the company can be 32.9% undervalued

Key Financials (Download financials)

Ticker: EHC
Share price, USD:  (0.0%)97.14
year average price 112.38  


year start price 99.86 2025-02-07

min close price 93.68 2025-03-13

max close price 127.18 2025-10-27

current price 97.14 2026-02-06
Common stocks: 99 796 703

Dividend Yield:  0.7%
FCF Yield LTM: 0.6%
EV / LTM EBITDA: 10.3x
EV / EBITDA annualized: 9.6x
Last revenue growth (y/y):  +10.0%
Last growth of EBITDA (y/y):  +23.3%
Historical revenue growth:  +7.2%
Historical growth of EBITDA:  +31.6%
EV / Sales: 2.2x
Margin (EBITDA LTM / Revenue): 21.6%
Fundamental value created in LTM:
Market Cap ($m): 9 694
Net Debt ($m): 3 479
EV (Enterprise Value): 13 173
Price to Book: 4.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-05zacks.com

Encompass Health (EHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

2026-02-05zacks.com

Encompass Health (EHC) Q4 Earnings and Revenues Top Estimates

2025-12-31zacks.com

Why You Should Add Encompass Health to Your Portfolio Now

2025-12-31zacks.com

All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy

2025-12-03zacks.com

EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand

2025-12-01zacks.com

Here's Why Encompass Health (EHC) is a Strong Value Stock

2025-11-26zacks.com

EHC Expands in Tennessee Via New JV Facility With Vanderbilt Health

2025-11-25prnewswire.com

Encompass Health and Vanderbilt Health announce plans to build a 40-bed inpatient rehabilitation hospital in Lebanon, Tennessee

2025-11-21prnewswire.com

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Fishers, Indiana

2025-11-14zacks.com

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161
fillingDate 2025-10-31 2025-08-06 2024-11-01 2024-08-06 2024-05-02 2023-11-01 2023-08-04 2023-05-03 2022-11-02
acceptedDate 2025-10-31 12:14:40 2025-08-06 16:19:07 2025-02-28 13:47:29 2024-11-01 14:39:01 2024-08-06 16:34:01 2024-05-01 18:01:51 2024-02-07 16:35:14 2023-11-01 15:30:10 2023-08-04 13:01:35 2023-05-03 12:55:04 2023-02-27 16:20:43 2022-11-02 16:30:20 2022-02-25 16:38:15 2021-02-26 16:25:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 1 478M 1 458M 5 373M 1 351M 1 301M 1 316M 4 801M 1 207M 1 187M 1 160M 4 349M 1 090M 4 015M 3 566M
costOfRevenue 785M 831M 3 140M 949M 1 035M 1 058M 2 818M 54M 52M 54M 2 595M 51M 2 312M 171M
grossProfit 693M 627M 2 233M 402M 266M 258M 1 983M 1 153M 1 135M 1 107M 1 753M 1 038M 1 703M 3 395M
grossProfitRatio 0.469 0.43 0.298 0.205 0.196 0.955 0.956 0.954 0.953
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 56M 74M 267M 54M 765M 776M 202M 723M 706M 686M 209M 656M 229M 2 117M
sellingAndMarketingExpenses 0 0 0 0 -715M -726M 56M 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 56M 74M 267M 54M 51M 50M 258M 723M 706M 686M 209M 656M 229M 2 117M
otherExpenses 393M 294M 1 102M 139M 3M 5M 0 500 000 3M 242M 914M 234M 816M 1 279M
operatingExpenses 449M 368M 1 369M 54M 51M 50M 258M 974M 951M 928M 1 123M 890M 1 044M 3 395M
costAndExpenses 1 234M 1 199M 4 509M 1 142M 1 086M 1 109M 3 076M 1 028M 1 003M 982M 3 718M 941M 3 356M 3 566M
interestIncome 0 0 0 0 0 0 0 36M 0 0 0 0 0 0
interestExpense 31M 30M 137M 35M 34M 35M 144M 36M 36M 36M 176M 38M 164M 184M
depreciationAndAmortization 82M 80M 300M 78M 73M 70M 274M 67M 73M 64M 244M 45M 220M 203M
ebitda 333M 347M 1 187M 297M 289M 278M 1 006M 248M 260M 247M 870M 151M 889M 740M
ebitdaratio 0.225 0.238 0.22 0.222 0.211 0.206 0.219 0.212 0.138
operatingIncome 244M 259M 865M 209M 216M 208M 1 725M 115M 118M 183M 630M 105M 659M 0
operatingIncomeRatio 0.165 0.178 0.155 0.166 0.158 0.095 0.1 0.157 0.097
totalOtherIncomeExpensesNet -24M -22M -115M -25M 38M -29M -1 118M 2M 4M -36M -179M 2M -154M 353M
incomeBeforeTax 220M 237M 750M 184M 186M 178M 607M 145M 151M 146M 451M 107M 505M 353M
incomeBeforeTaxRatio 0.149 0.162 0.136 0.143 0.136 0.12 0.127 0.126 0.098
incomeTaxExpense 45M 51M 150M 36M 38M 38M 132M 30M 33M 32M 100M 22M 102M 75M
netIncome 127M 142M 456M 108M 114M 113M 352M 85M 91M 88M 271M 86M 412M 284M
netIncomeRatio 0.086 0.097 0.08 0.088 0.085 0.071 0.077 0.076 0.078
eps 1.26 1.41 4.53 1.08 1.13 1.12 3.54 0.86 0.91 0.88 2.72 0.86 4.15 2.87
epsdiluted 1.24 1.39 1.06 1.12 1.1 0.84 0.9 0.87 0.85
weightedAverageShsOut 101M 101M 100M 100M 100M 100M 100M 100M 100M 99M 99M 99M 99M 99M
weightedAverageShsOutDil 102M 102M 102M 102M 102M 102M 101M 101M 101M 101M 100M 101M 100M 100M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-07 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -137M -144M -176M -164M -184M
ebit 887M 732M 627M 669M 537M
nonOperatingIncomeExcludingInterest -23M 993M 4M -10M -537M
netIncomeFromContinuingOperations 599M 475M 351M 403M 278M
netIncomeFromDiscontinuedOperations -3M -12M 15M 114M 91M
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 456M 352M 271M 412M 284M
epsDiluted 4.46 3.47 2.7 4.11 2.85

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161
fillingDate 2025-10-31 2025-08-06 2024-11-01 2024-08-06 2024-05-02 2023-11-01 2023-08-04 2023-05-03 2022-11-02
acceptedDate 2025-10-31 12:14:40 2025-08-06 16:19:07 2025-02-28 13:47:29 2024-11-01 14:39:01 2024-08-06 16:34:01 2024-05-01 18:01:51 2024-02-07 16:35:14 2023-11-01 15:30:10 2023-08-04 13:01:35 2023-05-03 12:55:04 2023-02-27 16:20:43 2022-11-02 16:30:20 2022-02-25 16:38:15 2021-02-26 16:25:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 49M 137M 85M 148M 182M 173M 104M 100M 118M 85M 22M 60M 49M 224M
shortTermInvestments 0 33M 0 41M 117M 113M 38M 37M 0 0 0 0 0 0
cashAndShortTermInvestments 49M 171M 85M 148M 299M 286M 142M 100M 118M 85M 22M 60M 49M 224M
netReceivables 611M 613M 599M 576M 590M 619M 612M 536M 532M 515M 537M 500M 502M 563M
inventory 0 0 0 0 0 0 0 42M 37M 34M 0 0 0 0
otherCurrentAssets 210M 135M 160M 210M 194M 25M 54M 137M 138M 128M 124M 174M 255M 75M
totalCurrentAssets 870M 918M 887M 934M 938M 930M 842M 814M 824M 762M 717M 734M 921M 949M
propertyPlantEquipmentNet 4 144M 4 036M 3 847M 3 733M 3 655M 3 569M 3 510M 3 383M 3 268M 3 201M 3 152M 3 003M 2 775M 2 452M
goodwill 1 303M 1 303M 1 284M 1 284M 1 284M 1 281M 1 281M 1 281M 1 271M 1 271M 1 263M 1 247M 1 237M 2 319M
intangibleAssets 292M 296M 298M 296M 303M 272M 278M 276M 278M 287M 282M 285M 158M 431M
goodwillAndIntangibleAssets 1 595M 1 599M 1 582M 1 580M 1 587M 1 554M 1 560M 1 558M 1 549M 1 558M 1 546M 1 532M 1 395M 2 750M
longTermInvestments 0 95M 123M 90M 117M 113M 110M -80M -83M 0 0 0 0 6M
taxAssets 0 0 0 97M 91M 94M 0 80M 83M 87M 0 0 0 0
otherNonCurrentAssets 257M 138M 97M 23M -100 001 -28M 82M 210M 220M 140M 222M 207M 1 773M 290M
totalNonCurrentAssets 5 996M 5 868M 5 648M 5 525M 5 451M 5 302M 5 261M 5 151M 5 037M 4 986M 4 919M 4 742M 5 944M 5 497M
otherAssets 0 0 0 0 1 1 0 0 0 0 0 0 0 0
totalAssets 6 866M 6 786M 6 535M 6 458M 6 389M 6 231M 6 102M 5 964M 5 861M 5 747M 5 637M 5 476M 6 865M 6 446M
accountPayables 138M 175M 171M 170M 164M 166M 170M 165M 156M 141M 133M 134M 134M 115M
shortTermDebt 65M 165M 115M 286M 86M 51M 49M 49M 49M 52M 25M 49M 19M 15M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 559M 526M 505M 441M 445M 463M 230M 425M 450M 399M 181M 422M 264M 174M
totalCurrentLiabilities 762M 865M 841M 897M 695M 680M 656M 639M 655M 592M 576M 605M 749M 717M
longTermDebt 2 597M 2 521M 2 065M 2 540M 2 886M 2 370M 2 369M 2 877M 2 890M 2 922M 2 742M 2 902M 2 851M 2 855M
deferredRevenueNonCurrent 0 0 0 0 202M 186M 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 108M 111M 105M 97M 91M 94M 87M 80M 83M 87M 83M 47M 0 0
otherNonCurrentLiabilities 213M 201M 190M 198M 187M 499M 178M 179M 176M 183M 174M 2 940M 297M 267M
totalNonCurrentLiabilities 2 917M 2 832M 2 845M 2 835M 3 164M 3 148M 3 149M 3 136M 3 149M 3 192M 3 199M 3 123M 3 717M 3 727M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 203M 483M 534M 222M 536M 499M 515M 209M 218M 226M 225M 206M 611M 674M
totalLiabilities 3 679M 3 698M 3 686M 3 733M 3 859M 3 828M 3 805M 3 775M 3 804M 3 784M 3 775M 3 728M 4 466M 4 444M
preferredStock 0 0 0 0 0 0 0 1 0 0 0 0 0 0
commonStock 1M 1M 1M 1M 1M 1M 1M 1M 0 1M 1M 1M 1M 1M
retainedEarnings 1 163M 1 056M 797M 693M 602M 504M 407M 334M 0 188M 116M 42M 142M -242M
accumulatedOtherComprehensiveIncomeLoss 500 000 300 000 0 0 0 0 0 0 0 0 0 0 0 0
othertotalStockholdersEquity 1 209M 1 223M 1 265M 1 236M 1 237M 1 225M 1 475M 1 194M 1 174M
totalStockholdersEquity 2 374M 2 280M 2 067M 1 960M 1 839M 1 742M 1 648M 1 560M 1 475M 1 384M 1 310M 1 217M 1 911M 1 588M
totalEquity 3 186M 3 088M 2 849M 2 016M 2 530M 2 403M 2 297M 2 189M 2 057M 1 384M 1 862M 1 217M 2 399M 2 002M
totalLiabilitiesAndStockholdersEquity 6 866M 6 786M 6 458M 6 389M 6 231M 5 964M 5 861M 5 747M 4 945M
minorityInterest 813M 808M 782M 57M 691M 662M 650M 629M 582M 580M 552M 0 488M 414M
totalLiabilitiesAndTotalEquity 6 866M 6 786M 6 535M 6 458M 6 389M 6 231M 6 102M 5 964M 5 861M 5 747M 5 637M 4 945M 6 865M 6 446M
totalInvestments 0 128M 123M 131M 235M 226M 147M -80M -83M 0 0 0 0 6M
totalDebt 2 662M 2 686M 2 714M 2 800M 2 945M 2 919M 2 933M 2 925M 2 939M 2 974M 2 992M 2 951M 3 481M 3 543M
netDebt 2 613M 2 548M 2 628M 2 652M 2 763M 2 747M 2 829M 2 826M 2 821M 2 889M 2 971M 2 891M 3 432M 3 319M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-07 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 599M 612M 537M 502M 563M
otherReceivables 0 0 0 0 0
prepaids 42M 35M 35M 115M 86M
totalPayables 171M 170M 133M 134M 115M
otherPayables 0 0 0 0 0
accruedExpenses 0 208M 211M 289M 345M
capitalLeaseObligationsCurrent 50M 0 26M 43M 69M
capitalLeaseObligationsNonCurrent 484M 515M 200M 569M 606M
treasuryStock -578M -547M -537M -521M -497M
additionalPaidInCapital 1 847M 1 787M 1 730M 2 290M 2 327M
otherTotalStockholdersEquity 0 0 0 -1 -0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC EHC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161 785 161
fillingDate 2025-10-31 2025-08-06 2024-11-01 2024-08-06 2024-05-02 2023-11-01 2023-08-04 2023-05-03 2022-11-02
acceptedDate 2025-10-31 12:14:40 2025-08-06 16:19:07 2025-02-28 13:47:29 2024-11-01 14:39:01 2024-08-06 16:34:01 2024-05-01 18:01:51 2024-02-07 16:35:14 2023-11-01 15:30:10 2023-08-04 13:01:35 2023-05-03 12:55:04 2023-02-27 16:20:43 2022-11-02 16:30:20 2022-02-25 16:38:15 2021-02-26 16:25:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 175M 185M 599M 148M 115M 113M 362M 115M 118M 114M 366M 67M 518M 284M
depreciationAndAmortization 82M 80M 300M 78M 73M 70M 274M 67M 73M 64M 244M 45M 220M 243M
deferredIncomeTax -2M -4M 11M -2M -2M 7M 4M -3M -4M 4M 28M 200 000 17M 52M
stockBasedCompensation 14M 14M 48M 13M 14M 9M 51M 14M 16M 8M 29M 5M 29M 26M
changeInWorkingCapital 2M -4M 22M 33M -12M -2M 50M 18M 4M 38M -30M -93M -118M 94M
accountsReceivables -3M 9M 3M 28M 9M -8M -22M 9M -12M 24M -17M -7M -64M -5M
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0
accountsPayables -30M -400 000 3M -400 000 6M -4M 12M -4M 3M 1M 2M -4M 15M 0
otherWorkingCapital 35M -13M 16M 5M -26M 10M 61M 13M 13M 13M -16M -82M -69M 99M
otherNonCashItems -200 000 -2M 23M -2M 176M 203M 111M 5M 300 000 -100 000 70M 46M 50M 6M
netCashProvidedByOperatingActivities 271M 270M 1 003M 268M 217M 239M 851M 215M 207M 228M 706M 70M 716M 705M
investmentsInPropertyPlantAndEquipment -187M -157M -643M -148M -157M -139M -583M -147M -117M -97M -584M -148M -551M -408M
acquisitionsNet 0 0 0 -33M 15M 18M 0 8M 0 0 64M 0 -119M -1M
purchasesOfInvestments -38M -128M -23M -20M 0 0 -23M -21M 0 0 -35M 0 -9M -9M
salesMaturitiesOfInvestments 28M 121M 19M 900 000 1 000 000 16M 0 13M 0 0 -64M 0 9M 13M
otherInvestingActivites -4M -2M 5M -3M -6M -16M -11M -7M -27M
netCashUsedForInvestingActivites -201M -165M -195M -144M -111M -162M -129M -104M -174M
debtRepayment -29M -22M -142M -12M -1 000 000 -27M -85M -46M -13M
commonStockIssued 0 0 0 0 0 400 000 0 0 0
commonStockRepurchased -25M -25M -31M -7M -17M -12M -8M -400 000 0 0 -7M 0 -15M -6M
dividendsPaid -17M -17M -15M -15M -16M -15M -15M -16M -28M
otherFinancingActivites -43M -26M -33M -21M -42M -24M 56M 3M -9M
netCashUsedProvidedByFinancingActivities -113M -90M -196M -65M -59M -66M -44M -58M -49M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 228M 89M 0 0 0 0 0
netChangeInCash -44M 15M 19M 17M 9M 69M 51M -13M 35M 66M -67M -153M -191M 151M
cashAtEndOfPeriod 94M 137M 123M 199M 182M 173M 104M 141M 154M 119M 53M 104M 120M 311M
cashAtBeginningOfPeriod 137M 123M 104M 182M 173M 104M 53M 154M 119M 53M 120M 257M 311M 160M
operatingCashFlow 271M 270M 1 003M 268M 217M 239M 851M 215M 207M 228M 706M 70M 716M 705M
capitalExpenditure -187M -157M -643M -148M -157M -139M -583M -147M -117M -97M -584M -148M -551M -408M
freeCashFlow 84M 113M 360M 120M 61M 99M 268M 69M 90M 131M 122M -77M 165M 297M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-07 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -7M 3M -8M 4M -2M
netCashProvidedByInvestingActivities -653M -603M -627M -666M -408M
netDebtIssuance -242M -83M -498M -59M 216M
longTermNetDebtIssuance -242M -83M -498M -59M 216M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -31M -8M -7M -15M -6M
netCommonStockIssuance -31M -8M -7M -15M -6M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -63M -60M -99M -112M -112M
commonDividendsPaid -63M -60M -99M -112M -112M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 5M -45M 459M -54M -244M
netCashProvidedByFinancingActivities -331M -197M -146M -240M -146M
incomeTaxesPaid 165M 109M 51M 131M 34M
interestPaid 147M 148M 178M 168M 168M

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-04-25 ET (fiscal 2025 q1)
2024 q4
2025-02-07 ET (fiscal 2024 q4)
2024 q3
2024-10-29 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-04-25 ET (fiscal 2024 q1)
2023 q4
2024-02-08 ET (fiscal 2023 q4)
2023 q3
2023-10-27 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-04-28 ET (fiscal 2023 q1)
2022 q4
2023-02-08 ET (fiscal 2022 q4)
2022 q3
2022-10-30 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-04-30 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-02-05 16:23 ET
Encompass Health Corporation published news for 2025 q4
SEC form 8
2026-02-05 16:23 ET
Encompass Health Corporation reported for 2025 q4
SEC form 8
2026-02-05 16:23 ET
Encompass Health Corporation published news for 2025 q4
SEC form 8
2025-10-29 20:22 ET
Encompass Health Corporation published news for 2025 q3
SEC form 8
2025-10-29 20:22 ET
Encompass Health Corporation reported for 2025 q3
SEC form 8
2025-10-29 20:22 ET
Encompass Health Corporation published news for 2025 q3
SEC form 8
2025-08-04 20:25 ET
Encompass Health Corporation published news for 2025 q2
SEC form 8
2025-08-04 20:25 ET
Encompass Health Corporation reported for 2025 q2
SEC form 8
2025-08-04 20:25 ET
Encompass Health Corporation published news for 2025 q2
SEC form 8
2025-06-25 20:28 ET
Encompass Health Corporation published news for 2025 q1
SEC form 8
2025-06-25 20:28 ET
Encompass Health Corporation published news for 2025 q1
SEC form 10
2025-05-01 19:25 ET
Encompass Health Corporation published news for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Encompass Health Corporation published news for 2025 q1
SEC form 8
2025-04-24 20:40 ET
Encompass Health Corporation published news for 2025 q1
SEC form 8
2025-04-24 20:40 ET
Encompass Health Corporation reported for 2025 q1
SEC form 8
2025-04-24 20:40 ET
Encompass Health Corporation published news for 2025 q1
SEC form 8
2025-04-24 20:40 ET
Encompass Health Corporation published news for 2025 q1
SEC form 10
2025-02-28 18:47 ET
Encompass Health Corporation published news for 2024 q4
SEC form 10
2025-02-28 00:00 ET
Encompass Health Corporation published news for 2024 q4
SEC form 8
2025-02-06 16:32 ET
Encompass Health Corporation published news for 2024 q4
SEC form 8
2025-02-06 16:32 ET
Encompass Health Corporation reported for 2024 q4
SEC form 8
2025-02-06 16:32 ET
Encompass Health Corporation published news for 2024 q4
SEC form 10
2024-11-01 14:39 ET
Encompass Health Corporation published news for 2024 q3
SEC form 8
2024-10-28 16:33 ET
Encompass Health Corporation published news for 2024 q3
SEC form 8
2024-10-28 16:33 ET
Encompass Health Corporation reported for 2024 q3
SEC form 8
2024-10-28 16:33 ET
Encompass Health Corporation published news for 2024 q3
SEC form 10
2024-08-06 16:34 ET
Encompass Health Corporation published news for 2024 q2
SEC form 10
2024-08-06 00:00 ET
Encompass Health Corporation published news for 2024 q2
SEC form 8
2024-08-05 17:00 ET
Encompass Health Corporation published news for 2024 q2
SEC form 8
2024-08-05 17:00 ET
Encompass Health Corporation reported for 2024 q2
SEC form 8
2024-08-05 17:00 ET
Encompass Health Corporation published news for 2024 q2
SEC form 10
2024-05-02 00:00 ET
Encompass Health Corporation published news for 2024 q1
SEC form 8
2024-04-24 16:28 ET
Encompass Health Corporation published news for 2024 q1
SEC form 8
2024-04-24 16:28 ET
Encompass Health Corporation reported for 2024 q1
SEC form 8
2024-04-24 16:28 ET
Encompass Health Corporation published news for 2024 q1
SEC form 10
2024-02-28 17:05 ET
Encompass Health Corporation published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Encompass Health Corporation published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
Encompass Health Corporation published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
Encompass Health Corporation reported for 2023 q4
SEC form 8
2024-02-07 00:00 ET
Encompass Health Corporation published news for 2023 q4
SEC form 10
2023-11-01 00:00 ET
Encompass Health Corporation published news for 2023 q3
SEC form 8
2023-10-26 16:36 ET
Encompass Health Corporation reported for 2023 q3
SEC form 10
2023-08-04 00:00 ET
Encompass Health Corporation published news for 2023 q2
SEC form 6
2023-08-01 16:35 ET
Encompass Health Corporation reported for 2023 q2
SEC form 8
2023-08-01 00:00 ET
Encompass Health Corporation published news for 2023 q2
SEC form 6
2023-07-25 16:32 ET
Encompass Health Corporation published news for 2023 q2
SEC form 10
2023-05-03 00:00 ET
Encompass Health Corporation published news for 2023 q1
SEC form 8
2023-04-27 00:00 ET
Encompass Health Corporation published news for 2023 q1
SEC form 6
2023-03-14 16:35 ET
Encompass Health Corporation published news for 2022 q4
SEC form 6
2023-02-27 17:23 ET
Encompass Health Corporation published news for 2022 q4
SEC form 10
2023-02-27 16:20 ET
Encompass Health Corporation reported for 2022 q4
SEC form 10
2023-02-27 00:00 ET
Encompass Health Corporation reported for 2022 q4
SEC form 6
2023-02-08 18:47 ET
Encompass Health Corporation published news for 2022 q4
SEC form 6
2023-02-07 16:38 ET
Encompass Health Corporation published news for 2022 q4
SEC form 8
2023-02-07 00:00 ET
Encompass Health Corporation reported for 2022 q4
SEC form 6
2022-12-13 16:31 ET
Encompass Health Corporation published news for 2022 q3
SEC form 6
2022-11-14 08:18 ET
Encompass Health Corporation published news for 2022 q3
SEC form 10
2022-11-02 16:30 ET
Encompass Health Corporation published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Encompass Health Corporation reported for 2022 q3
SEC form 6
2022-10-26 17:27 ET
Encompass Health Corporation published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
Encompass Health Corporation reported for 2022 q3
SEC form 6
2022-10-13 16:22 ET
Encompass Health Corporation published news for 2022 q3
SEC form 10
2022-08-04 13:19 ET
Encompass Health Corporation published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Encompass Health Corporation reported for 2022 q2
SEC form 6
2022-08-01 17:08 ET
Encompass Health Corporation published news for 2022 q2
SEC form 8
2022-08-01 00:00 ET
Encompass Health Corporation reported for 2022 q2
SEC form 6
2022-07-07 16:48 ET
Encompass Health Corporation published news for 2022 q2
SEC form 6
2022-06-21 17:14 ET
Encompass Health Corporation published news for 2022 q1
SEC form 6
2022-06-13 08:18 ET
Encompass Health Corporation published news for 2022 q1
SEC form 6
2022-06-07 17:05 ET
Encompass Health Corporation published news for 2022 q1
SEC form 6
2022-06-07 08:03 ET
Encompass Health Corporation published news for 2022 q1
SEC form 6
2022-05-09 16:36 ET
Encompass Health Corporation published news for 2022 q1
SEC form 10
2022-05-03 17:18 ET
Encompass Health Corporation published news for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Encompass Health Corporation reported for 2022 q1
SEC form 6
2022-04-27 16:46 ET
Encompass Health Corporation published news for 2022 q1
SEC form 8
2022-04-27 00:00 ET
Encompass Health Corporation reported for 2022 q1
SEC form 6
2022-04-04 14:53 ET
Encompass Health Corporation published news for 2022 q1
SEC form 6
2022-03-31 12:05 ET
Encompass Health Corporation published news for 2021 q4
SEC form 6
2022-03-31 08:22 ET
Encompass Health Corporation published news for 2021 q4
SEC form 6
2022-03-16 08:02 ET
Encompass Health Corporation published news for 2021 q4
SEC form 10
2022-02-25 16:38 ET
Encompass Health Corporation published news for 2021 q4
SEC form 10
2022-02-25 00:00 ET
Encompass Health Corporation published news for 2021 q4
SEC form 6
2022-02-01 16:42 ET
Encompass Health Corporation published news for 2021 q4
SEC form 8
2022-02-01 00:00 ET
Encompass Health Corporation published news for 2021 q4
SEC form 6
2022-01-25 17:10 ET
Encompass Health Corporation published news for 2021 q4
SEC form 6
2021-12-16 17:35 ET
Encompass Health Corporation published news for 2021 q3
SEC form 6
2021-12-09 08:34 ET
Encompass Health Corporation published news for 2021 q3
SEC form 10
2021-11-02 13:00 ET
Encompass Health Corporation published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Encompass Health Corporation published news for 2021 q3
SEC form 6
2021-10-27 16:25 ET
Encompass Health Corporation published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
Encompass Health Corporation published news for 2021 q3
SEC form 6
2021-10-26 21:47 ET
Encompass Health Corporation published news for 2021 q3
SEC form 6
2021-09-07 08:06 ET
Encompass Health Corporation published news for 2021 q2
SEC form 10
2021-08-03 16:54 ET
Encompass Health Corporation published news for 2021 q2
SEC form 10
2021-08-03 00:00 ET
Encompass Health Corporation published news for 2021 q2
SEC form 6
2021-07-28 17:22 ET
Encompass Health Corporation published news for 2021 q2
SEC form 6
2021-07-27 17:04 ET
Encompass Health Corporation published news for 2021 q2
SEC form 8
2021-07-27 00:00 ET
Encompass Health Corporation published news for 2021 q2
SEC form 6
2021-06-21 16:28 ET
Encompass Health Corporation published news for 2021 q1
SEC form 6
2021-05-10 19:40 ET
Encompass Health Corporation published news for 2021 q1
SEC form 10
2021-05-04 17:06 ET
Encompass Health Corporation published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Encompass Health Corporation published news for 2021 q1
SEC form 6
2021-04-27 16:22 ET
Encompass Health Corporation published news for 2021 q1
SEC form 8
2021-04-27 00:00 ET
Encompass Health Corporation published news for 2021 q1
SEC form 6
2021-04-02 08:33 ET
Encompass Health Corporation published news for 2021 q1
SEC form 6
2021-03-26 12:24 ET
Encompass Health Corporation published news for 2020 q4
SEC form 6
2021-03-09 07:55 ET
Encompass Health Corporation published news for 2020 q4
SEC form 10
2021-02-26 16:25 ET
Encompass Health Corporation published news for 2020 q4
SEC form 6
2021-01-26 16:24 ET
Encompass Health Corporation published news for 2020 q4
SEC form 6
2020-12-09 08:31 ET
Encompass Health Corporation published news for 2020 q3
SEC form 6
2020-11-13 16:27 ET
Encompass Health Corporation published news for 2020 q3
SEC form 10
2020-11-02 16:47 ET
Encompass Health Corporation published news for 2020 q3
SEC form 6
2020-10-28 16:23 ET
Encompass Health Corporation published news for 2020 q3
SEC form 6
2020-10-05 13:24 ET
Encompass Health Corporation published news for 2020 q3